Direct Correlation of Cell Toxicity to Conformational Ensembles of Genetic Aβ Variants

被引:14
|
作者
Somavarapu, Arun Kumar [1 ]
Kepp, Kasper P. [1 ]
机构
[1] Tech Univ Denmark, DTU Chem, DK-2800 Lyngby, Denmark
来源
ACS CHEMICAL NEUROSCIENCE | 2015年 / 6卷 / 12期
关键词
Amyloid beta; Alzheimer's disease; structural ensembles; toxicity; coil; PRECURSOR PROTEIN GENE; ALZHEIMER-DISEASE MUTATIONS; MOLECULAR-DYNAMICS; SYNAPTIC PLASTICITY; CEREBRAL-HEMORRHAGE; SECONDARY STRUCTURE; FORCE-FIELDS; TOTTORI D7N; ENGLISH H6R; APP GENE;
D O I
10.1021/acschemneuro.5b00238
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report a systematic analysis of conformational ensembles generated from multiseed molecular dynamics simulations of all 15 known genetic variants of A beta(42). We show that experimentally determined variant toxicities are largely explained by random coil content of the amyloid ensembles (correlation with smaller EC50 values; R-2 = 0.54, p = 0.01), and to some extent the helix character (more helix-character is less toxic, R-2 = 0.32, p = 0.07) and hydrophobic surface (R-2 = 0.37, p = 0.04). Our findings suggest that qualitative structural features of the amyloids, rather than the quantitative levels, are fundamentally related to neurodegeneration. The data provide molecular explanations for the high toxicity of E22 variants and for the protective features of the recently characterized A2T variant. The identified conformational features, for example, the local helix-coil-strand transitions of the C-terminals of the peptides, are of likely interest in the direct targeting of amyloids by rational drug design.
引用
收藏
页码:1990 / 1996
页数:7
相关论文
共 50 条
  • [31] Validation of genetic variants associated to late severe toxicity after prostate cancer RT
    Cicchetti, A.
    Rancati, T.
    Ballarini, F.
    Dispinzieri, M.
    Giandini, T.
    Avuzzi, B.
    Cozzarini, C.
    Fiorino, C.
    Valdagni, R.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S452 - S453
  • [32] Putative role of genetic variants of eNOS in survival and toxicity of patients given antiangiogenic therapy
    Del Re, M.
    Fontana, A.
    Del Re, I.
    Bona, E.
    Salvadori, B.
    Ferrarini, I.
    Landucci, E.
    Fancelli, S.
    Bertolini, I.
    Michelotti, A.
    Falcone, A.
    Danesi, R.
    CANCER RESEARCH, 2013, 73
  • [33] Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy
    Saraf, Santosh L.
    Zhang, Xu
    Shah, Binal
    Kanias, Tamir
    Gudehithlu, Krishnamurthy P.
    Kittles, Rick
    Machado, Roberto F.
    Arruda, Jose A. L.
    Gladwin, Mark T.
    Singh, Ashok K.
    Gordeuk, Victor R.
    HAEMATOLOGICA, 2015, 100 (10) : 1275 - 1284
  • [34] THE BONE CHANGES IN SICKLE CELL ANAEMIA AND ITS GENETIC VARIANTS
    GOLDING, JSR
    MACIVER, JE
    WENT, LN
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1959, 41 (04): : 711 - 718
  • [35] Genetic Variants Regulating Immune Cell Levels in Health and Disease
    Orru, Valeria
    Steri, Maristella
    Sole, Gabriella
    Sidore, Carlo
    Virdis, Francesca
    Dei, Mariano
    Lai, Sandra
    Zoledziewska, Magdalena
    Busonero, Fabio
    Mulas, Antonella
    Floris, Matteo
    Mentzen, Wieslawa I.
    Urru, Silvana A. M.
    Olla, Stefania
    Marongiu, Michele
    Piras, Maria G.
    Lobina, Monia
    Maschio, Andrea
    Pitzalis, Maristella
    Urru, Maria F.
    Marcelli, Marco
    Cusano, Roberto
    Deidda, Francesca
    Serra, Valentina
    Oppo, Manuela
    Pilu, Rosella
    Reinier, Frederic
    Berutti, Riccardo
    Pireddu, Luca
    Zara, Ilenia
    Porcu, Eleonora
    Kwong, Alan
    Brennan, Christine
    Tarrier, Brendan
    Lyons, Robert
    Kang, Hyun M.
    Uzzau, Sergio
    Atzeni, Rossano
    Valentini, Maria
    Firinu, Davide
    Leoni, Lidia
    Rotta, Gianluca
    Naitza, Silvia
    Angius, Andrea
    Congia, Mauro
    Whalen, Michael B.
    Jones, Chris M.
    Schlessinger, David
    Abecasis, Goncalo R.
    Fiorillo, Edoardo
    CELL, 2013, 155 (01) : 242 - 256
  • [36] ISOZYMIC VARIANTS AS GENETIC MARKERS IN SOMATIC CELL POPULATIONS IN VITRO
    RUDDLE, FH
    NATIONAL CANCER INSTITUTE MONOGRAPHS, 1968, (29): : 9 - &
  • [37] Genetic variants modulating hemoglobin F/F cell levels
    Thein, SL
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 273 - 273
  • [38] The implications of genetic variants on human pluripotent stem cell characteristics
    Stavish, D.
    Price, C.
    Barbaric, I.
    HUMAN GENE THERAPY, 2019, 30 (08) : A18 - A18
  • [39] Correlation between Sialylation Status and Cell Susceptibility to Amyloid Toxicity
    Sgambati, Eleonora
    Tani, Alessia
    Leri, Manuela
    Delfino, Giovanni
    Zecchi-Orlandini, Sandra
    Bucciantini, Monica
    Nosi, Daniele
    CELLS, 2022, 11 (04)
  • [40] Conformational variation between allelic variants of cell-surface ovine prion protein
    Thackray, AM
    Yang, SJ
    Wong, E
    Fitzmaurice, TJ
    Morgan-Warren, RJ
    Bujdoso, R
    BIOCHEMICAL JOURNAL, 2004, 381 : 221 - 229